v3.25.4
Income Taxes - Schedule of Net Deferred Tax Assets (Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Capitalized research and development $ 398,547 $ 295,779
Deduction on subsidiary equity carryforwards 395,115 393,960
Operating loss carryforwards 394,614 307,413
Intangible assets 264,002 243,391
Tax credit carryforwards 190,819 127,483
Accrued liabilities 130,948 115,290
Share-based compensation 47,878 47,486
Indirect effects of unrecognized tax benefits 31,625 35,000
Other 16,175 15,714
Total deferred tax assets 1,869,723 1,581,516
Valuation allowance (529,674) (509,190)
Deferred tax assets, net of valuation allowance 1,340,049 1,072,326
Deferred tax liabilities:    
Intangible assets (1,041,150) (1,130,485)
Inventories (13,532) (47,802)
Other (10,707) (10,530)
Total deferred tax liabilities (1,065,389) (1,188,817)
Net deferred tax assets (liabilities) $ 274,660  
Net deferred tax assets (liabilities)   $ (116,491)